NURS 60441 PHARMACOTHERAPEUTICS FOR ADVANCED PRACTICE
f f f f f f
NURSE PRESCRIBERS, 5TH EDITION TEST BANK FINAL EXAM QUESTI
f f f f f f f f
ONS AND ANSWERS BEST RATED A+ GUARANTEED SUCCESS LATEST
f f f f f f f f f
UPDATE 2022 f
Chapter 18. Drugs Affecting the Endocrine System: Pancreatic Hormones and Antidiabetic Dr
f f f f f f f f f f f
ugs
• Patients with cystic fibrosis are often prescribed enzyme replacement for pancreatic secreti
f f f f f f f f f f f
ons. Each replacement drug has lipase, protease, and amylase components, but the drug is p
f f f f f f f f f f f f f f
rescribed in units of: f f f
a. Lipase
b. Protease
c. Amylase
d. Pancreatin
• Brands of pancreatic enzyme replacement drugs are:
f f f f f f
a. Bioequivalent
b. About the same in cost per unit of lipase across brands
f f f f f f f f f f
c. Able to be interchanged between generic and brand-name products to reduce cost
f f f f f f f f f f f
d. None of the above f f f
• When given subcutaneously, how long until neutral protamine Hagedorn insulin begins to take e
f f f f f f f f f f f f f
ffect (onsetof action) after administration?
f f f f f
a. 15 to 30 minutes f f f
b. 60 to 90 minutes f f f
c. 3 to 4 hours f f f
d. 6 to 8 hours f f f
• Hypoglycemia can result from the action of either insulin or an oral hypoglycemic. Signs and sy
f f f f f f f f f f f f f f f
NURS 60441 PHARMACOTHERAPEUTICS FOR ADVANCED PRACTICE
f f f f f f
NURSE PRESCRIBERS, 5TH EDITION TEST BANK FINAL EXAM QUESTI
f f f f f f f f
ONS AND ANSWERS BEST RATED A+ GUARANTEED SUCCESS LATEST
f f f f f f f f f
UPDATE 2022 f
,NURS 60441 PHARMACOTHERAPEUTICS FOR ADVANCED PRACTICE
f f f f f f
NURSE PRESCRIBERS, 5TH EDITION TEST BANK FINAL EXAM QUESTI
f f f f f f f f
ONS AND ANSWERS BEST RATED A+ GUARANTEED SUCCESS LATEST
f f f f f f f f f
UPDATE 2022 f
mptoms ofhypoglycemia include:
f f f
a. “Fruity” breath odor and rapid respiration f f f f f
b. Diarrhea, abdominal pain, weight loss, and hypert f f f f f f
ensionc. Dizziness, confusion, diaphoresis, and tach
f f f f f f
ycardia
d. Easy bruising, palpitations, cardiac dysrhythmias, and coma
f f f f f f f
• Nonselective beta blockers and alcohol create serious drug interactions with insulin because they:
f f f f f f f f f f f f
a. Increase blood glucose levels f f f
b. Produce unexplained diaphoresis f f
c. Interfere with the ability of the body to metabolize gl f f f f f f f f f
ucosed. Mask the signs and symptoms of altered glucose
f f f f f f f f f
f levels
• Lispro is an insulin analogue produced by recombinant DNA technology. Wh
f f f f f f f f f f
ich of thefollowing statements about this form of insulin is NOT true?
f f f f f f f f f f f f
a. Optimal time of preprandial injection is 15 minutes. f f f f f f f
b. Duration of action is increased when the dose is increased. f f f f f f f f f
c. It is compatible with neutral protamine Hagedorn insulin.
f f f f f f f
d. It has no pronounced peak.
f f f f
• The decision may be made to switch from twice daily neutral protamine Hagedor
f f f f f f f f f f f f
n (NPH)insulin to insulin glargine to improve glycemia control throughout the d
f f f f f f f f f f f f
ay. If this is done:
f f f f
NURS 60441 PHARMACOTHERAPEUTICS FOR ADVANCED PRACTICE
f f f f f f
NURSE PRESCRIBERS, 5TH EDITION TEST BANK FINAL EXAM QUESTI
f f f f f f f f
ONS AND ANSWERS BEST RATED A+ GUARANTEED SUCCESS LATEST
f f f f f f f f f
UPDATE 2022 f
,NURS 60441 PHARMACOTHERAPEUTICS FOR ADVANCED PRACTICE
f f f f f f
NURSE PRESCRIBERS, 5TH EDITION TEST BANK FINAL EXAM QUESTI
f f f f f f f f
ONS AND ANSWERS BEST RATED A+ GUARANTEED SUCCESS LATEST
f f f f f f f f f
UPDATE 2022 f
a. The initial dose of glargine is reduced by 20% to avoid hypoglycemia.
f f f f f f f f f f f
b. The initial dose of glargine is 2 to 10 units per day.
f f f f f f f f f f f
c. Patients who have been on high doses of NPH will need tests for insulin antibodies.
f f f f f f f f f f f f f f
d. Obese patients may require more than 100 units per day.
f f f f f f f f f
• When blood glucose levels are difficult to control in type 2 diabetes some form of ins
f f f f f f f f f f f f f f f
ulin maybe added to the treatment regimen to control blood glucose and limit compli
f f f f f f f f f f f f f f
cation risks. f
Which ofthe following statements is accurate based on research?
f f f f f f f f
a. Premixed insulin analogues are better at lowering HbA1C and have less f f f f f f f f f f f
risk forhypoglycemia.
f f
b. Premixed insulin analogues and the newer premixed insulins are associated w f f f f f f f f f f
ith moreweight gain than the oral antidiabetic agents.
f f f f f f f f
c. Newer premixed insulins are better at lowering HbA1C and postprandia
f f f f f f f f f
l glucoselevels than long-acting insulins.
f f f f f
d. Patients who are not controlled on oral agents and have postprandial hyperg
f f f f f f f f f f f
lycemiacan have neutral protamine Hagedorn insulin added at bedtime.
f f f f f f f f f
• Metformin is a primary choice of drug to treat hyperglycemia in type 2 diabetes because it:
f f f f f f f f f f f f f f f
a. Substitutes for insulin usually secreted by the pa f f f f f f f
ncreasb. Decreases glycogenolysis by the liver
f f f f f f
c. Increasesfthefreleasefoffinsulinffromfbetafcells
d. Decreasesfperipheralfglucosefutilization
• Prior to prescribing metformin, the provider should:
f f f f f f
NURS 60441 PHARMACOTHERAPEUTICS FOR ADVANCED PRACTICE
f f f f f f
NURSE PRESCRIBERS, 5TH EDITION TEST BANK FINAL EXAM QUESTI
f f f f f f f f
ONS AND ANSWERS BEST RATED A+ GUARANTEED SUCCESS LATEST
f f f f f f f f f
UPDATE 2022 f
, NURS 60441 PHARMACOTHERAPEUTICS FOR ADVANCED PRACTICE
f f f f f f
NURSE PRESCRIBERS, 5TH EDITION TEST BANK FINAL EXAM QUESTI
f f f f f f f f
ONS AND ANSWERS BEST RATED A+ GUARANTEED SUCCESS LATEST
f f f f f f f f f
UPDATE 2022 f
a. Draw a serum creatinine to assess renal function
f f f f f f f
b. Try the patient on insulin
f f f f
c. Tell the patient to increase iodine intake
f f f f f f
d. Have the patient stop taking any sulfonylurea to avoid dangerous drug interactions
f f f f f f f f f f f
• The action of “gliptins” is different from other antidiabetic agents because they:
f f f f f f f f f f f
a. Have a low risk for hypoglycemia f f f f f
b. Are not associated with weight gain
f f f f f
c. Close ATP-dependent potassium channels in the beta cell
f f f f f f f
d. Act on the incretin system to indirectly increase insulin production
f f f f f f f f f
• Sitagliptin has been approved for: f f f f
a. Monotherapy in once-daily doses f f f
b. Combination therapy with metformin f f f
c. Both 1 and 2 f f f f
d. Neither 1 nor 2 f f f
• GLP-1 agonists: f
a. Directly bind to a receptor in the pancreatic beta cell f f f f f f f f f
b. Have been approved for monotherapy f f f f
c. Speed gastric emptying to decrease appetite f f f f f
d. Can be given orally once daily
f f f f f
• Avoid concurrent administration of exenatide with which of the following drugs?
f f f f f f f f f f
a. Digoxin
NURS 60441 PHARMACOTHERAPEUTICS FOR ADVANCED PRACTICE
f f f f f f
NURSE PRESCRIBERS, 5TH EDITION TEST BANK FINAL EXAM QUESTI
f f f f f f f f
ONS AND ANSWERS BEST RATED A+ GUARANTEED SUCCESS LATEST
f f f f f f f f f
UPDATE 2022 f
f f f f f f
NURSE PRESCRIBERS, 5TH EDITION TEST BANK FINAL EXAM QUESTI
f f f f f f f f
ONS AND ANSWERS BEST RATED A+ GUARANTEED SUCCESS LATEST
f f f f f f f f f
UPDATE 2022 f
Chapter 18. Drugs Affecting the Endocrine System: Pancreatic Hormones and Antidiabetic Dr
f f f f f f f f f f f
ugs
• Patients with cystic fibrosis are often prescribed enzyme replacement for pancreatic secreti
f f f f f f f f f f f
ons. Each replacement drug has lipase, protease, and amylase components, but the drug is p
f f f f f f f f f f f f f f
rescribed in units of: f f f
a. Lipase
b. Protease
c. Amylase
d. Pancreatin
• Brands of pancreatic enzyme replacement drugs are:
f f f f f f
a. Bioequivalent
b. About the same in cost per unit of lipase across brands
f f f f f f f f f f
c. Able to be interchanged between generic and brand-name products to reduce cost
f f f f f f f f f f f
d. None of the above f f f
• When given subcutaneously, how long until neutral protamine Hagedorn insulin begins to take e
f f f f f f f f f f f f f
ffect (onsetof action) after administration?
f f f f f
a. 15 to 30 minutes f f f
b. 60 to 90 minutes f f f
c. 3 to 4 hours f f f
d. 6 to 8 hours f f f
• Hypoglycemia can result from the action of either insulin or an oral hypoglycemic. Signs and sy
f f f f f f f f f f f f f f f
NURS 60441 PHARMACOTHERAPEUTICS FOR ADVANCED PRACTICE
f f f f f f
NURSE PRESCRIBERS, 5TH EDITION TEST BANK FINAL EXAM QUESTI
f f f f f f f f
ONS AND ANSWERS BEST RATED A+ GUARANTEED SUCCESS LATEST
f f f f f f f f f
UPDATE 2022 f
,NURS 60441 PHARMACOTHERAPEUTICS FOR ADVANCED PRACTICE
f f f f f f
NURSE PRESCRIBERS, 5TH EDITION TEST BANK FINAL EXAM QUESTI
f f f f f f f f
ONS AND ANSWERS BEST RATED A+ GUARANTEED SUCCESS LATEST
f f f f f f f f f
UPDATE 2022 f
mptoms ofhypoglycemia include:
f f f
a. “Fruity” breath odor and rapid respiration f f f f f
b. Diarrhea, abdominal pain, weight loss, and hypert f f f f f f
ensionc. Dizziness, confusion, diaphoresis, and tach
f f f f f f
ycardia
d. Easy bruising, palpitations, cardiac dysrhythmias, and coma
f f f f f f f
• Nonselective beta blockers and alcohol create serious drug interactions with insulin because they:
f f f f f f f f f f f f
a. Increase blood glucose levels f f f
b. Produce unexplained diaphoresis f f
c. Interfere with the ability of the body to metabolize gl f f f f f f f f f
ucosed. Mask the signs and symptoms of altered glucose
f f f f f f f f f
f levels
• Lispro is an insulin analogue produced by recombinant DNA technology. Wh
f f f f f f f f f f
ich of thefollowing statements about this form of insulin is NOT true?
f f f f f f f f f f f f
a. Optimal time of preprandial injection is 15 minutes. f f f f f f f
b. Duration of action is increased when the dose is increased. f f f f f f f f f
c. It is compatible with neutral protamine Hagedorn insulin.
f f f f f f f
d. It has no pronounced peak.
f f f f
• The decision may be made to switch from twice daily neutral protamine Hagedor
f f f f f f f f f f f f
n (NPH)insulin to insulin glargine to improve glycemia control throughout the d
f f f f f f f f f f f f
ay. If this is done:
f f f f
NURS 60441 PHARMACOTHERAPEUTICS FOR ADVANCED PRACTICE
f f f f f f
NURSE PRESCRIBERS, 5TH EDITION TEST BANK FINAL EXAM QUESTI
f f f f f f f f
ONS AND ANSWERS BEST RATED A+ GUARANTEED SUCCESS LATEST
f f f f f f f f f
UPDATE 2022 f
,NURS 60441 PHARMACOTHERAPEUTICS FOR ADVANCED PRACTICE
f f f f f f
NURSE PRESCRIBERS, 5TH EDITION TEST BANK FINAL EXAM QUESTI
f f f f f f f f
ONS AND ANSWERS BEST RATED A+ GUARANTEED SUCCESS LATEST
f f f f f f f f f
UPDATE 2022 f
a. The initial dose of glargine is reduced by 20% to avoid hypoglycemia.
f f f f f f f f f f f
b. The initial dose of glargine is 2 to 10 units per day.
f f f f f f f f f f f
c. Patients who have been on high doses of NPH will need tests for insulin antibodies.
f f f f f f f f f f f f f f
d. Obese patients may require more than 100 units per day.
f f f f f f f f f
• When blood glucose levels are difficult to control in type 2 diabetes some form of ins
f f f f f f f f f f f f f f f
ulin maybe added to the treatment regimen to control blood glucose and limit compli
f f f f f f f f f f f f f f
cation risks. f
Which ofthe following statements is accurate based on research?
f f f f f f f f
a. Premixed insulin analogues are better at lowering HbA1C and have less f f f f f f f f f f f
risk forhypoglycemia.
f f
b. Premixed insulin analogues and the newer premixed insulins are associated w f f f f f f f f f f
ith moreweight gain than the oral antidiabetic agents.
f f f f f f f f
c. Newer premixed insulins are better at lowering HbA1C and postprandia
f f f f f f f f f
l glucoselevels than long-acting insulins.
f f f f f
d. Patients who are not controlled on oral agents and have postprandial hyperg
f f f f f f f f f f f
lycemiacan have neutral protamine Hagedorn insulin added at bedtime.
f f f f f f f f f
• Metformin is a primary choice of drug to treat hyperglycemia in type 2 diabetes because it:
f f f f f f f f f f f f f f f
a. Substitutes for insulin usually secreted by the pa f f f f f f f
ncreasb. Decreases glycogenolysis by the liver
f f f f f f
c. Increasesfthefreleasefoffinsulinffromfbetafcells
d. Decreasesfperipheralfglucosefutilization
• Prior to prescribing metformin, the provider should:
f f f f f f
NURS 60441 PHARMACOTHERAPEUTICS FOR ADVANCED PRACTICE
f f f f f f
NURSE PRESCRIBERS, 5TH EDITION TEST BANK FINAL EXAM QUESTI
f f f f f f f f
ONS AND ANSWERS BEST RATED A+ GUARANTEED SUCCESS LATEST
f f f f f f f f f
UPDATE 2022 f
, NURS 60441 PHARMACOTHERAPEUTICS FOR ADVANCED PRACTICE
f f f f f f
NURSE PRESCRIBERS, 5TH EDITION TEST BANK FINAL EXAM QUESTI
f f f f f f f f
ONS AND ANSWERS BEST RATED A+ GUARANTEED SUCCESS LATEST
f f f f f f f f f
UPDATE 2022 f
a. Draw a serum creatinine to assess renal function
f f f f f f f
b. Try the patient on insulin
f f f f
c. Tell the patient to increase iodine intake
f f f f f f
d. Have the patient stop taking any sulfonylurea to avoid dangerous drug interactions
f f f f f f f f f f f
• The action of “gliptins” is different from other antidiabetic agents because they:
f f f f f f f f f f f
a. Have a low risk for hypoglycemia f f f f f
b. Are not associated with weight gain
f f f f f
c. Close ATP-dependent potassium channels in the beta cell
f f f f f f f
d. Act on the incretin system to indirectly increase insulin production
f f f f f f f f f
• Sitagliptin has been approved for: f f f f
a. Monotherapy in once-daily doses f f f
b. Combination therapy with metformin f f f
c. Both 1 and 2 f f f f
d. Neither 1 nor 2 f f f
• GLP-1 agonists: f
a. Directly bind to a receptor in the pancreatic beta cell f f f f f f f f f
b. Have been approved for monotherapy f f f f
c. Speed gastric emptying to decrease appetite f f f f f
d. Can be given orally once daily
f f f f f
• Avoid concurrent administration of exenatide with which of the following drugs?
f f f f f f f f f f
a. Digoxin
NURS 60441 PHARMACOTHERAPEUTICS FOR ADVANCED PRACTICE
f f f f f f
NURSE PRESCRIBERS, 5TH EDITION TEST BANK FINAL EXAM QUESTI
f f f f f f f f
ONS AND ANSWERS BEST RATED A+ GUARANTEED SUCCESS LATEST
f f f f f f f f f
UPDATE 2022 f
